The Risk of Early Recurrent Venous Thromboembolism after Oral Anticoagulant Therapy in Patients with the G20210A Transition in the Prothrombin Gene
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
Nonparametric Estimation from Incomplete Observations
1992 • 45,923 citations
Nonparametric Estimation from Incomplete Observations
1958 • 37,219 citations
Mutation in blood coagulation factor V associated with resistance to activated protein C
1994 • 3,871 citations
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
1996 • 3,124 citations
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
1996 • 2,090 citations
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 • 1,467 citations
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
1996 • 1,331 citations
A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism
1995 • 950 citations
Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families
1994 • 446 citations
The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)
1997 • 380 citations
Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S
1995 • 314 citations
The 20210 A Allele of the Prothrombin Gene Is a Common Risk Factor among Swedish Outpatients with Verified Deep Venous Thrombosis
1997 • 255 citations
Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism
1995 • 251 citations
Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency
1996 • 237 citations
The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden
1997 • 206 citations
The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population
1997 • 172 citations
Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.
1992 • 151 citations
Mutation in blood coagulation factor V associated with resistance to activated protein C
1995 • 145 citations
Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families
1994 • 29 citations